hotspot -WSS

hotspot

author：knowledge 2025-10-04 10:47:37 Page View：2671

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： Structure Therapeutics oral GLP
Next article： Alkermes shareholders re

knowledge

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

How CO2 helps viruses stay alive longer in the air

AdobeCarbondioxidemonitorshavebeenaroundfordecades.Butin2020,theybecame,almostovernight,ahotcommodit

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

HPV cancer vaccine study demonstrates efficacy

JoeRaedle/GettyImagesVaccinesworkwelltopreventcancerscausedbythehumanpapillomavirus(HPV).Sowell,infa

hotspot

leisure time

knowledge

HPV cancer vaccine study demonstrates efficacy